- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05595902
Normative Value for Navicular Drop Test in Older Adults
July 28, 2026 updated by: Nilufer Kablan, Istanbul Medeniyet University
Determination of Normative Values of Navicular Height and Navicular Drop Amount in Geriatric Individuals and Investigation of the Effect of Age, Gender and Body Mass Index on Normative Values
The aim of this study is to determine the normative values of navicular height and navicular drop in individuals over 65 years of age.
The secondary aim is to investigate the effects of age, gender, and body mass index on these normative values.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Istanbul
-
Kadıköy, Istanbul, Turkey (Türkiye), 34000
- Nilüfer Kablan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Healthy older adults
Description
Inclusion Criteria:
- Being 65 years or older
- Having a body mass index between 18.5 and 29.0 kg/m2
Exclusion Criteria:
- Having chronic diseases that affect the foot structure and connective tissue (such as diabetes mellitus, rheumatoid arthritis, gout, etc.).
- Have had foot or ankle surgery in the last 6 months
- Having orthopedic or neurological deformities (related to stroke, Parkinson's, multiple sclerosis, spinal cord injury, etc.) that will affect the foot structure and mobility.
- Dependence on standing and ambulation (except independence gained through the use of assistive devices)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
|---|
|
Young older adults
≥65-<75 years of age
|
|
Older adults
≥75-<90 years of age
|
|
≥90 years old
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Navicular Drop Test
Time Frame: 10 minutes
|
The navicular height and the amount of navicular drop will be made separately for each foot.
The navicular prominence is found by palpation and marked with a marker pen when the individual is in a sitting position with the hips and knees flexed to 90 degrees and the subtalar joint in neutral position (the subtalar joint is palpated and the talus is in a neutral position).
The height of the navicular protrusion from the ground is measured with a rigid ruler.
Then, while the person stands on both feet equally, the height of the navicular protrusion from the ground is also measured with a ruler.
The difference between the two measurements is noted as the amount of "navicular drop" (NDT).
|
10 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Age
Time Frame: 1 minute
|
Age
|
1 minute
|
|
Gender
Time Frame: 1 minute
|
Gender
|
1 minute
|
|
Body-Mass index
Time Frame: 3 minutes
|
weight/ (height)2
|
3 minutes
|
|
Foot Posture Index
Time Frame: 15 minutes
|
FPI
|
15 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2023
Primary Completion (Actual)
May 1, 2024
Study Completion (Actual)
August 1, 2025
Study Registration Dates
First Submitted
October 24, 2022
First Submitted That Met QC Criteria
October 24, 2022
First Posted (Actual)
October 27, 2022
Study Record Updates
Last Update Posted (Actual)
July 30, 2026
Last Update Submitted That Met QC Criteria
July 28, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- IstanbulMU81
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.